X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1860) 1860
Book Review (341) 341
Publication (152) 152
Book Chapter (41) 41
Dissertation (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1466) 1466
humans (1337) 1337
cytomegalovirus (874) 874
female (772) 772
cmv (711) 711
male (671) 671
adult (628) 628
transplantation (609) 609
immunology (568) 568
middle aged (554) 554
cytomegalovirus infections (503) 503
infection (427) 427
cytomegalovirus - immunology (401) 401
health aspects (395) 395
cmv infection (394) 394
virus diseases (367) 367
cytomegalovirus infections - immunology (360) 360
disease (357) 357
aged (319) 319
cytomegalovirus infections - virology (317) 317
recipients (311) 311
hematology (305) 305
adolescent (297) 297
risk factors (293) 293
cytomegalovirus infections - diagnosis (287) 287
infectious diseases (278) 278
virology (278) 278
cytomegalovirus - isolation & purification (255) 255
antiviral agents - therapeutic use (238) 238
cytomegalovirus infections - prevention & control (221) 221
infections (220) 220
t cells (220) 220
young adult (216) 216
cytomegalovirus - genetics (215) 215
ganciclovir (203) 203
stem cells (190) 190
hematopoietic stem cells (184) 184
prevention (183) 183
viral load (183) 183
retrospective studies (181) 181
bone-marrow-transplantation (175) 175
child (173) 173
polymerase chain reaction (173) 173
cytomegalovirus infections - epidemiology (172) 172
cytomegalovirus infections - drug therapy (169) 169
analysis (165) 165
oncology (165) 165
cytomegalovirus - physiology (161) 161
hematopoietic stem cell transplantation - adverse effects (153) 153
microbiology (153) 153
mortality (153) 153
transplantation, homologous (153) 153
antiviral agents (152) 152
preemptive therapy (152) 152
transplants & implants (151) 151
risk-factors (148) 148
reactivation (147) 147
cytomegalovirus infections - complications (145) 145
pregnancy (144) 144
cytomegalovirus infections - etiology (143) 143
diagnosis (136) 136
research (135) 135
viruses (135) 135
animals (132) 132
cmv disease (132) 132
ganciclovir - therapeutic use (132) 132
prophylaxis (131) 131
surgery (129) 129
hematopoietic stem cell transplantation (128) 128
antibodies, viral - blood (126) 126
dna (126) 126
organ transplant recipients (126) 126
therapy (126) 126
dna, viral - blood (125) 125
polymerase-chain-reaction (125) 125
cd8-positive t-lymphocytes - immunology (123) 123
lymphocytes (123) 123
stem-cell transplantation (123) 123
child, preschool (122) 122
risk (122) 122
virus (119) 119
human cytomegalovirus (118) 118
infant (117) 117
immunotherapy (116) 116
virus activation (116) 116
cytomegalovirus-infection (114) 114
cmv reactivation (109) 109
medical research (108) 108
infant, newborn (107) 107
stem cell transplantation (106) 106
treatment outcome (104) 104
transplant recipients (103) 103
children (102) 102
prospective studies (102) 102
hiv (99) 99
kidney transplantation (98) 98
prevalence (97) 97
care and treatment (96) 96
cytomegalovirus infections - blood (96) 96
immunity (95) 95
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1836) 1836
French (27) 27
German (12) 12
Japanese (6) 6
Spanish (6) 6
Czech (3) 3
Turkish (3) 3
Hungarian (2) 2
Korean (2) 2
Polish (2) 2
Portuguese (2) 2
Croatian (1) 1
Italian (1) 1
Persian (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 12, pp. 2192 - 2202
Abstract The relative contribution of human cytomegalovirus (HMCV)–specific CD4+ and CD8+ T cells to the control of HCMV infection in hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | CD8+ T cells | Hematopoietic stem cell transplantation | Human cytomegalovirus | Specific T cell immunity | CD4+ T cells | Gastrointestinal disease | CD4 | CD8 | Specific T cell immunity | T cells | (HCMV)-SPECIFIC CD4(+) | CD8(+) | DENDRITIC CELLS | PREEMPTIVE THERAPY | IMMUNOLOGY | BONE-MARROW-TRANSPLANT | VERSUS-HOST-DISEASE | TRANSPLANTATION | RESPONSES | CMV REACTIVATION | CD8(+) T cells | IDENTIFY PATIENTS | SIMULTANEOUS QUANTIFICATION | HEMATOLOGY | CD4(+) T cells | CD8-Positive T-Lymphocytes - pathology | Cell Proliferation | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Cytomegalovirus Infections - immunology | Hematologic Neoplasms - pathology | CD4-Positive T-Lymphocytes - pathology | Graft vs Host Disease - immunology | Transplantation, Homologous | Cytomegalovirus Infections - mortality | CD4-Positive T-Lymphocytes - immunology | Graft vs Host Disease - mortality | Adult | Female | Cytomegalovirus Infections - pathology | Retrospective Studies | CD4-Positive T-Lymphocytes - virology | Virus Activation | Cytomegalovirus - pathogenicity | Antiviral Agents - therapeutic use | Risk Factors | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Graft vs Host Disease - pathology | Cytomegalovirus - immunology | Graft vs Host Disease - drug therapy | CD8-Positive T-Lymphocytes - virology | Cytomegalovirus Infections - drug therapy | CD8-Positive T-Lymphocytes - drug effects | Survival Analysis | Hematologic Neoplasms - drug therapy | Aged | Hematologic Neoplasms - immunology | CD8-Positive T-Lymphocytes - immunology | Chronic Disease | CD4-Positive T-Lymphocytes - drug effects | Index Medicus
Journal Article
European Journal of Immunology, ISSN 0014-2980, 06/2018, Volume 48, Issue 6, pp. 950 - 964
Journal Article
Blood, ISSN 0006-4971, 2016, Volume 127, Issue 20, pp. 2427 - 2438
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 08/2008, Volume 8, Issue 8, pp. 1749 - 1754
Journal Article
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 09/2019, Volume 19, Issue 9, pp. 2399 - 2400
The author comments on the importance of Zhang et al's ( page 2421 ) observation that ischemia and reperfusion can trigger CMV reactivation after solid organ... 
IRI | editorial/personal viewpoint | infectious disease | kidney transplantation/nephrology | ischemia reperfusion injury | CMV | infection and infectious agents – viral: cytomegalovirus | Cytomegalovirus infections | Communicable diseases | Cytomegalovirus | Transplantation | Reperfusion | Ischemia | Index Medicus
Journal Article
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 08/2010, Volume 12, Issue 4, pp. 322 - 329
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 248 - 256
Immune checkpoint inhibitors can cause severe immune-related adverse events, with immune-related diarrhea and colitis (irColitis) being among the most frequent... 
Checkpoint inhibition | Colitis | CMV | Melanoma | SOLID-ORGAN TRANSPLANTATION | MANAGEMENT | ULCERATIVE-COLITIS | UNTREATED MELANOMA | METASTATIC MELANOMA | INFLAMMATORY-BOWEL-DISEASE | ONCOLOGY | PHASE-3 TRIAL | DOUBLE-BLIND | INFECTION | IPILIMUMAB | Predictive Value of Tests | Skin Neoplasms - drug therapy | Colitis - virology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cytomegalovirus Infections - chemically induced | Cytomegalovirus Infections - immunology | Antibodies, Viral - blood | Opportunistic Infections - chemically induced | Young Adult | Time Factors | Colitis - chemically induced | Aged, 80 and over | Cytomegalovirus Infections - virology | Ganciclovir - therapeutic use | Adult | Female | Colitis - drug therapy | Opportunistic Infections - immunology | Colitis - immunology | Cytomegalovirus - pathogenicity | Skin Neoplasms - pathology | Cytomegalovirus - genetics | Opportunistic Infections - virology | Skin Neoplasms - immunology | Antiviral Agents - therapeutic use | Risk Factors | Hospitals, University | Treatment Outcome | Melanoma - secondary | Host-Pathogen Interactions | Cytomegalovirus - immunology | Antineoplastic Agents, Immunological - adverse effects | Virus Activation - drug effects | Cytomegalovirus Infections - drug therapy | Melanoma - immunology | Melanoma - drug therapy | Opportunistic Infections - drug therapy | Adolescent | Aged | Immunocompromised Host | DNA, Viral - genetics | Germany | Cytomegalovirus - drug effects | Prevention | Care and treatment | Corticosteroids | Cytomegalovirus infections | Cancer | Corticoids | Immunoglobulin M | Therapy | Dermatology | Immunomodulation | infliximab | Diarrhea | Activation | Metastasis | Tumor necrosis factor-α | Patients | Immunosuppressive agents | Metastases | Demographics | Inhibitors | Immune checkpoint | Immunotherapy | Monoclonal antibodies | Diagnostic systems | Colon | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Journal Article